Form D · Biotechnology
Atea Pharmaceuticals, Inc.
Boston, MA · CIK 0001593899
Offering snapshot reported May 29, 2020 · SEC filing
- Reported sold
- $107M Offering amount: $215M
- Investors reported
- 37 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 19, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 29, 2020 | Initial | $107,499,941 | No comparison | 37 | SEC filing |
| Jul 16, 2018 | Initial | $27,599,934 | No comparison | 38 | SEC filing |
| Sep 13, 2016 | Initial | $20,829,775 | No comparison | 29 | SEC filing |
| Sep 17, 2014 | Amendment | $20,000,000 | No comparison | 59 | SEC filing |
| May 21, 2014 | Amendment | $14,740,000 | No comparison | 43 | SEC filing |
| Dec 11, 2013 | Initial | Yet to sell | No comparison | 0 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $500K
- Finders' fees
- $0
- Form D file number
- 021-367951
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| William Blair | 1252 |
Source: Form D, filed May 29, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Franklin Berger | Director |
| Grigory Borisenko | Director |
| Gerald Chan | Director |
| Bihua Chen | Director |
| Isaac Cheng, M.D. | Director |
| Andrea Corcoran | Executive |
| Andrew Hack, M.D., Ph.D. | Director |
| Bruno Lucidi | Director |
| Bruce Polsky | Director |
| Jean Pierre Sommadossi | Director, Executive |
| Jean Pierre Sommadossi, Ph.D. | Director, Executive |
| Fan Yu | Director |
| Frank Yu | Director |
| Evgeny Zatsev | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
125 Summer St. 16 Th Floor
Boston, MA, 02110
Boston, MA, 02110